Bradykinin-induced Internalization of the Human B2Receptor Requires Phosphorylation of Three Serine and Two Threonine Residues at Its Carboxyl Tail*

Abstract

The binding of bradykinin (BK) to B2 receptor triggers the internalization of the agonist-receptor complex. To investigate the mechanisms and the receptor structures involved in this fundamental process of receptor regulation, the human B2 receptor was mutated within its cytoplasmic tail by complementary strategies of truncation, deletion, and amino acid substitution. Ligand binding, signal transduction, internalization as well as phosphorylation were studied for the mutated receptors expressed in COS, CHO, and HEK 293 cells. Truncation of 44 out of 55 amino acid residues of the receptor’s cytoplasmic tail corresponding to positions 321–364 did not alter the kinetics of BK binding and the receptor coupling to phospholipase C and phospholipase A2. By contrast, truncations after positions 320 and 334, deletions within the segment covering positions 335–351, as well as alanine substitution of serine and threonine residues within segment 335–351 diminished the internalization capacity of the mutant receptors. Mutants with a markedly reduced internalization potential failed to produce BK-induced receptor phosphorylation suggesting that phosphorylation may be involved in receptor internalization. The mutagenesis approaches converged at the conclusion that three serines in positions 339, 346, and 348 and two threonines in positions 342 and 345, contained in a sequence segment that is highly conserved between species, have a critical role in the ligand-dependent internalization and phosphorylation of kinin receptors and can intervene in these processes in an alternative manner. However, mutants lacking these residues were still sensitive to dominant-negative forms of β-arrestin and dynamin, suggesting the existence of additional receptor structure(s) involved in the receptor sequestration through clathrin-coated vesicles.

Footnotes

  • * This work was supported by INSERM and grants from the Bristol-Meyers Squibb Institute for Medical Research (Princeton, NJ) and the Deutsche Forschungsgemeinschaft.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

  • § Supported by a grant from La Fondation Pour la Recherche Medicale. To whom correspondence should be addressed. Tel.: 33-1-45-87-61-00; Fax: 33-1-45-35-66-29; E-mail: pizard{at}ifm.inserm.fr.

  • Present address: Ludwig Institute for Cancer Research, P.O. Box 595, S-75124 Uppsala, Sweden.

  • 2 A. Faussner and A. Blaukat, unpublished observations.

  • Abbreviations:
    GPCRs

    G protein-coupled receptors

    HBSS

    Hank’s buffered saline solution

    BK

    bradykinin

    B2wt

    human B2 BK wild-type receptor

    COSB2wt

    COS-7 cells overexpressing the B2wt

    PLC

    phospholipase C

    PLA2

    phospholipase A2

    BSA

    bovine serum albumin

    IPs

    inositol phosphates

    [Ca2+]i

    intracellular Ca2+

    CHO

    Chinese hamster ovary

    PKC

    protein kinase C

    PMA

    phorbol 12-myristate 13-acetate

    PAGE

    polyacrylamide gel electrophoresis

    • Received August 12, 1998.
    • Revision received January 21, 1999.
« Previous | Next Article »Table of Contents
  • Advertisement
  • Advertisement
Advertisement